EUVIMEDEUVIMED entdecken
Video/Audio

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Jingyu Mao, Qin Lu, Fei Gao, Hao Liu, Jinchuan Tan

Journal of Visualized Experiments · 2024

DOI: 10.3791/66179 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2024. Verfasst von Jingyu Mao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hebei University of Chinese Medicine. Hauptthemen laut MEDLINE: Diabetic Nephropathies, ErbB Receptors, Drugs, Chinese Herbal, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to delve into the mechanisms underpinning Jiawei Shengjiang San's (JWSJS) action in treating diabetic nephropathy and deploying network pharmacology. Employing network pharmacology and molecular docking techniques, we predicted the active components and targets of JWSJS and constructed a meticulous "drug-component-target" network. Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses were utilized to discern the therapeutic pathways and targets of JWSJS. Autodock Vina 1.2.0 was deployed for molecular docking verification, and a 100-ns molecular dynamics simulation was conducted to affirm the docking results, followed by in vivo animal verification. The findings revealed that JWSJS shared 227 intersecting targets with diabetic nephropathy, constructing a protein-protein interaction network topology. KEGG enrichment analysis denoted that JWSJS mitigates diabetic nephropathy by modulating lipids and atherosclerosis, the PI3K-Akt signaling pathway, apoptosis, and the HIF-1 signaling pathway, with mitogen-activated protein kinase 1 (MAPK1), MAPK3, epidermal growth factor receptor (EGFR), and serine/threonine-protein kinase 1 (AKT1) identified as collective targets of multiple pathways. Molecular docking asserted that the core components of JWSJS (quercetin, palmitoleic acid, and luteolin) could stabilize conformation with three pivotal targets (MAPK1, MAPK3, and EGFR) through hydrogen bonding. In vivo examinations indicated notable augmentation in body weight and reductions in glycated serum protein (GSP), low-density lipoprotein cholesterol (LDL-C), uridine triphosphate (UTP), and fasting blood glucose (FBG) levels due to JWSJS. Electron microscopy coupled with hematoxylin and eosin (HE) and Periodic acid-Schiff (PAS) staining highlighted the potential of each treatment group in alleviating kidney damage to diverse extents, exhibiting varied declines in p-EGFR, p-MAPK3/1, and BAX, and increments in BCL-2 expression in the kidney tissues of the treated rats. Conclusively, these insights suggest that the protective efficacy of JWSJS on diabetic nephropathy might be associated with suppressing the activation of the EGFR/MAPK3/1 signaling pathway and alleviating renal cell apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesErbB ReceptorsDrugs, Chinese HerbalMolecular Docking SimulationDiabetes Mellitus, ExperimentalSignal TransductionAnimalsRatsMitogen-Activated Protein Kinase 3MaleMAP Kinase Signaling SystemRats, Sprague-DawleyMitogen-Activated Protein Kinase 1Network PharmacologyDisease Models, Animal

Substanzen

ErbB ReceptorsDrugs, Chinese HerbalMitogen-Activated Protein Kinase 3Egfr protein, ratMitogen-Activated Protein Kinase 1

Autor:innen und Institutionen

  • Graduate School, Hebei University of Chinese Medicine.
  • School of Basic Medical Sciences, Hebei University of Chinese Medicine.
  • Department of Endocrinology and Nephrology, Renal Research Institute of Beijing University of Chinese Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine.
  • Hebei Province Academy of Chinese Medicine Sciences; 1095755878@qq.com.
  • Department of Nephrology, First Affiliated Hospital, Hebei University of Chinese Medicine; liuhaomjy@163.com.

Zitieren

APA

Mao, J., Lu, Q., Gao, F., Liu, H., & Tan, J. (2024). Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway. Journal of Visualized Experiments. https://doi.org/10.3791/66179

Vancouver

Mao J, Lu Q, Gao F, Liu H, Tan J. Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway. Journal of Visualized Experiments. 2024. doi:10.3791/66179

BibTeX
@article{Mao2024,
  author = {Mao, Jingyu and Lu, Qin and Gao, Fei and Liu, Hao and Tan, Jinchuan},
  title = {Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway},
  journal = {Journal of Visualized Experiments},
  year = {2024},
  doi = {10.3791/66179}
}
Kostenlos starten →